Artivion (AORT) Asset Writedowns and Impairment (2010 - 2024)
Artivion's (AORT) quarterly Asset Writedowns and Impairment came in at $3.9 million in Q4 2024, up 501.34% YoY from $645387.3 in Q1 2024, and up 506.41% on a QoQ basis from $640000.0 in Q3 2024.
Artivion (AORT) Asset Writedowns and Impairment (2010 - 2024) Analysis & Trends
Artivion (AORT) has 7 years of Asset Writedowns and Impairment data on file, last reported at $3.9 million in Q4 2024.
- Quarterly Asset Writedowns and Impairment rose 501.34% year-over-year to $3.9 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $5.7 million (up 319.66% YoY) and the FY2024 annual result came in at $5.7 million, up 319.66% from the prior year.
- Asset Writedowns and Impairment improved to $3.9 million in Q4 2024, from $640000.0 in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $4.9 million in Q4 2021 to a low of -$1.5 million in Q3 2021.
- A 4-year average of $931437.5 and a median of $642000.0 in 2024 frame the typical range for Asset Writedowns and Impairment.
- Annual changes were most pronounced in 2023 — Asset Writedowns and Impairment slumped 229.8% — and 2024, when it surged 501.34%.
- Tracing AORT's Asset Writedowns and Impairment over 4 years: stood at $4.9 million in 2021, then slumped by 84.8% to $745000.0 in 2022, then tumbled by 229.8% to -$967000.0 in 2023, then surged by 501.34% to $3.9 million in 2024.
- The last three Asset Writedowns and Impairment figures came in at $3.9 million (Q4 2024), $640000.0 (Q3 2024), and $534000.0 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Artivion | 1.36 Bn | 1.28 Bn | 80.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 3.88 Mn |
| Dec 31, 2024 | 3.88 Mn |
| Sep 30, 2024 | 640,000.00 |
| Sep 30, 2024 | 640,000.00 |
| Jun 30, 2024 | 534,000.00 |
| Jun 30, 2024 | 534,000.00 |
| Mar 31, 2024 | 644,000.00 |
| Mar 31, 2024 | 644,000.00 |
| Dec 31, 2023 | -967,000.00 |
| Dec 31, 2023 | -967,000.00 |
| Sep 30, 2023 | 489,000.00 |
| Sep 30, 2023 | 489,000.00 |
| Jun 30, 2023 | 1.08 Mn |
| Jun 30, 2023 | 1.08 Mn |
| Mar 31, 2023 | 754,000.00 |
| Mar 31, 2023 | 754,000.00 |
| Dec 31, 2022 | 745,000.00 |
| Dec 31, 2022 | 745,000.00 |
| Sep 30, 2022 | 583,000.00 |
| Sep 30, 2022 | 583,000.00 |